Cargando…
Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells
Background: Naltrexone is an opioid receptor antagonist commonly used to treat opioid and alcohol dependence. The use of low dose naltrexone (LDN) was found to have anti-inflammatory properties for treatment of diseases such as fibromyalgia, Crohn’s disease, multiple sclerosis and regional pain synd...
Autores principales: | Kučić, Natalia, Rački, Valentino, Šverko, Roberta, Vidović, Toni, Grahovac, Irena, Mršić-Pelčić, Jasenka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395119/ https://www.ncbi.nlm.nih.gov/pubmed/34445130 http://dx.doi.org/10.3390/ijms22168429 |
Ejemplares similares
-
Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
por: Racki, Valentino, et al.
Publicado: (2021) -
Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies
por: Pilipović, Kristina, et al.
Publicado: (2022) -
Plant-Based Antioxidants for Prevention and Treatment of Neurodegenerative Diseases: Phytotherapeutic Potential of Laurus nobilis, Aronia melanocarpa, and Celastrol
por: Pilipović, Kristina, et al.
Publicado: (2023) -
The Exercise Training Modulatory Effects on the Obesity-Induced Immunometabolic Dysfunctions
por: Soltani, Nakisa, et al.
Publicado: (2020) -
Microglia Gone Awry: Linking Immunometabolism to Neurodegeneration
por: Afridi, Ruqayya, et al.
Publicado: (2020)